Amanote Research
Register
Sign In
RNA Interference Targeting Aurora-A Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy
Oncology Letters
- Greece
doi 10.3892/ol.2016.5261
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 14, 2016
Authors
Jing Gan
Fangfang Wang
Dezhi Mu
Yi Qu
Rong Luo
Qiu Wang
Publisher
Spandidos Publications
Related search
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
Cancers
Cancer Research
Oncology
Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27
Acta Pharmacologica Sinica
Medicine
Pharmacology
Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition
Oncology Reports
Medicine
Cancer Research
Oncology
Epigenetic Preconditioning With Decitabine Sensitizes Glioblastoma to Temozolomide via Induction of MLH1
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Regulation of the Oxidative Balance With Coenzyme Q10 Sensitizes Human Glioblastoma Cells to Radiation and Temozolomide
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway
Anatomical Record
Evolution
Ecology
Systematics
Anatomy
Histology
Behavior
Biotechnology
Efficient Inhibition of Human Telomerase Reverse Transcriptase Expression by RNA Interference Sensitizes Cancer Cells to Ionizing Radiation and Chemotherapy
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Bone Morphogenetic Protein 7 Sensitizes O6-Methylguanine Methyltransferase Expressing-Glioblastoma Stem Cells to Clinically Relevant Dose of Temozolomide
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma
Oncotarget
Oncology
